Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for upcoming IPOs.
Momentum from previous two weeks finally built up to Budweiser Brewing Company APAC (1876 HK) and ESR Cayman (ESR HK) relaunching their IPO. Budweiser APAC re-filed its PHIP whiled ESR Cayman re-filed its draft prospectus. Sumeet Singh provided updates from Budweiser's new PHIP and trade ideas surrounding the mega IPO.
Shanghai Henlius Biotech (2696 HK) also launched its IPO bookbuild this week, looking to raise up to US$477m. Ke Yan, CFA, FRM looked at the company's valuation and the seemingly positive newsflow in the midst of IPO bookbuild.
Other IPOs that are looking to launch in the coming weeks are Home Credit (HC HK) and Topsports International (TOP HK), which has just filed its PHIP this week. China Mobile Games Adr (CMGE US) is also looking to seek listing approval next week. We have covered the IPOs in:
ECM activity in other countries have also been looking up. Asset World Corporation (AWC TB) and AllHome (HOME PM) launched their IPO bookbuild this week while Home Consortium has set terms for its IPO.
We are also hearing that Metro Pacific Hospital Holdings is looking to IPO soon in the Philippines and, for the longest time, we are waiting for Lendlease REIT's prospectus to be filed on MAS website as the bookbuilding was last said to be launching in the coming weeks.
Our overall accuracy rate is 72.7% for IPOs and 64.5% for Placements
(Performance measurement criteria is explained at the end of the note)
Below is a snippet of our IPO tool showing upcoming events for the next week. The IPO tool is designed to provide readers with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up expiry, etc) for all the deals that we have worked on. You can access the tool here or through the tools menu.
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.